CTRI/2020/09/027904
Not Yet Recruiting
N/A
Autologous whole blood injection as treatment for Covid-19 infection
Dr M Christopher0 sites0 target enrollmentTBD
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
- Sponsor
- Dr M Christopher
- Status
- Not Yet Recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\) Patients in the age group of 14 years and above
- •2\) Both male and female patients
- •3\) Confirmed cases of COVID 19 admitted for treatment in Shifa hospital; COVID positive confirmed by RT\-PCR
- •4\) Presence of IgM antibodies through rapid test kit
- •5\) Willing to give consent for the study and take part actively
- •6\) Patients willing to adhere to drugs protocol as per ICMR guidelines/ WHO guidelines
- •7\) In test arm, patients who are accepting to AWB therapy in addition to standard drugs
Exclusion Criteria
- •1\) Children lesser than 14 years of age
- •2\) Presence of IgG antibodies through rapid test kit
- •3\) Patients hypersensitive to blood products or blood transfusion
- •4\) Any Co\-morbid conditions
- •5\) Patients who are critically ill are excluded from the study
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
N/A
Clinical Study of autologous blood injection for the treatment of recurrent temporomandibular joint dislocatioJPRN-UMIN000022197Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences Department of Oral and Maxillofacial Surgery20
Not Yet Recruiting
N/A
Autologous Peripheral Blood Stem Cell Treatment for Myocardial Regeneration in Acute Myocardial InfarctioDiseases of the circulatory systemKCT0006114Seoul National University Hospital105
Completed
N/A
Autologous conditioned plasma injection for acute hamstring muscle injury.hamstring rupturehamstring strain10028302NL-OMON37939Arthrex Medizinische Instrumente GmbH80
Terminated
N/A
Application of autologous peripheral blood-derived stem cell/progenitor cell (CD34+) + stem cells and hyperbaric oxygen therapy for patients with severe limb ischemiaISRCTN80181257Ministry of Science and Technology (Taiwan)40
Unknown
N/A
Peripheral blood mononuclear cell implantation for patients with severe ischemic heart diseaseSevere ischemic heart diseaseJPRN-UMIN000001289Department of Cardiovascular Science and Medicine,Graduate School of Medicine,Chiba University30